Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 10/20 | 0.93 |
| ▸ | TSHR | P16473 | 3/20 | 0.93 |
| ▸ | LMNA | P02545 | 3/20 | 0.93 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.93 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.93 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.93 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.93 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.93 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.93 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.93 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.86 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.86 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.86 |
| ▸ | KDR | P35968 | 1/20 | 0.86 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.86 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.68 |
| ▸ | CA12 | O43570 | 1/20 | 0.62 |
| ▸ | CA1 | P00915 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butylparaben SCHEMBL31393220 | 1.00 | ESR1 (0.93) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL5789201 | 0.96 | ESR1 (1.00) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL3647 | 0.96 | ESR1 (1.00) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL16862676 | 0.95 | ESR1 (0.84) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL9172319 | 0.95 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL2325184 | 0.95 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL761983 | 0.95 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL29376702 | 0.95 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL5152448 | 0.95 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 | |
| Butylparaben SCHEMBL29377478 | 0.95 | ESR1 (0.96) | ESR1TSHRLMNACYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7666451-B2 | Method of treating dyshidrosis(pompholyx) and related dry skin disorders | MAZZIO ELIZABETH ANNE | 2010-02-23 | — | — | US | claimed |
| US-20090004301-A1 | Method of treating dyshidrosis(pompholyx) and related dry skin disorders | MAZZIO ELIZABETH | 2009-01-01 | — | — | US | claimed |
| US-7357950-B2 | Topical treatment for dyshidrosis (pompholyx) and dry skin disorders | MAZZIO ELIZABETH ANNE | 2008-04-15 | — | — | US | claimed |
| US-20040185123-A1 | Topical treatment for dyshidrosis (pompholyx) and dry skin disorders | MAZZIO ELIZABETH A (US) | 2004-09-23 | — | — | US | claimed |
| CN-117531228-A | Use of coconut water as extraction solvent | 巴斯夫美容护理法国公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-117355290-A | Hair coloring composition for reducing color loss | 路博润先进材料公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-110167527-B | Use of coconut water as extraction solvent | 巴斯夫美容护理法国公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-112118831-B | Tabletted chewing gum sweet suitable for active pharmaceutical ingredient | 费尔廷制药公司 | 2023-04-21 | — | — | CN | disclosed |
| EP-3781211-A1 | POWDER COMPOSITION FOR COSMETIC AND HEALTH USE | Speximo AB (SE) | 2021-02-24 | — | — | EP | disclosed |
| WO-2019203717-A1 | POWDER COMPOSITION FOR COSMETIC AND HEALTH USE | SPEXIMO AB (SE) | 2019-10-24 | — | — | WO | disclosed |
| EP-2421494-B1 | METHOD FOR PRODUCING FREE POWDER PARTICLES OF POLYAMIDE IMPREGNATED WITH AT LEAST ONE COSMETIC OR PHARMACEUTICAL AGENT, AND FREE POWDER PARTICLES OF POLYAMIDE HAVING A CONTENT OF AT LEAST 25 WT % OF AT LEAST ONE COSMETIC OR PHARMACEUTICAL AGENT | ARKEMA FRANCE (FR) | 2018-02-07 | — | — | EP | disclosed |
| US-9764167-B2 | Method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent, and free powder particles of polyamide having a content of at least 25 WT % of a cosmetic or pharmaceutical agent other than water | ARKEMA FRANCE (FR) | 2017-09-19 | — | — | US | disclosed |
| EP-1423448-A4 | POLYMERIC URETHANE ESTER QUATS AND THEIR USE IN PERSONAL CARE COMPOSITIONS | ALZO INT INC (US) | 2005-06-29 | — | — | EP | disclosed |
| EP-1423448-A2 | POLYMERIC URETHANE ESTER QUATS AND THEIR USE IN PERSONAL CARE COMPOSITIONS | Alzo International, Inc. (US) | 2004-06-02 | — | — | EP | disclosed |
| WO-2003016247-A2 | POLYMERIC URETHANE ESTER QUATS AND THEIR USE IN PERSONAL CARE COMPOSITIONS | ALZO INTERNATIONAL, INC. (US) | 2003-02-27 | — | — | WO | disclosed |
| US-5972317-A | NAIL-PERMEABLE MEDICATION MEANS IS DISCLOSED FOR DELIVERING A MEDICAMENT THROUGH NAILS, CLAWS, HOOFS, OR OTHER SIMILAR HARDENED TISSUE OF DERMAL DERIVATION; INCLUDES PROTEOLYTIC ENZYME AND DRUG SELECTED TO TREAT SPECIFIC DISEASE | SORENSON PHARMACEUTICAL, INC. (US) | 1999-10-26 | — | — | US | disclosed |
| EP-0866683-A4 | COMPOSITION AND METHOD FOR TREATING DISEASED NAILS | SORENSON PHARMACEUTICAL INC (US) | 1999-01-07 | — | — | EP | disclosed |
| US-5840283-A | NAIL-PERMEABLE COMPOSITION COMPRISING PROTEOLYTIC ENZYME AND DISEASE AFFECTING MEDICAMENT IN TOPICALLY SPREADABLE FORM | SORENSON PHARMACEUTICAL, INC. (US) | 1998-11-24 | — | — | US | disclosed |
| EP-0866683-A1 | COMPOSITION AND METHOD FOR TREATING DISEASED NAILS | Sorenson Pharmaceutical, Inc. (US) | 1998-09-30 | — | — | EP | disclosed |
| WO-1997009960-A1 | COMPOSITION AND METHOD FOR TREATING DISEASED NAILS | SORENSON PHARMACEUTICAL, INC. (US) | 1997-03-20 | — | — | WO | disclosed |